Connect
MJA
MJA

Lung cancer: let’s try for prevention and cure

Ian N Olver
Med J Aust 2013; 199 (10): . || doi: 10.5694/mja13.11278
Published online: 18 November 2013

Emphasising prevention and ensuring best practice through access to continually updated treatment guidelines are needed to improve outcomes

In this issue of the Journal, Mitchell and colleagues report a follow-up survey from Victoria on the management of lung cancer, 10 years after an initial survey in 1993.1 The issues of therapeutic nihilism,2 variation in management and poor survival remain, but it is encouraging that there are improvements. Moreover, the follow-up was until 2003 so that 5-year results after that time could be reported, and further advances have undoubtedly occurred in the subsequent decade.


  • Cancer Council Australia, Sydney, NSW.


Correspondence: ian.olver@cancer.org.au

Competing interests:

No relevant disclosures.

  • 1. Mitchell PLR, Thursfield VJ, Ball DL, et al. Lung cancer in Australia: are we making progress? Med J Aust 2013; 199: 674-679. <MJA full text>
  • 2. Chamber S, Dunn J, Occhipinti S, et al. A systematic review of the impact of stigma and nihilism on lung cancer outcomes. BMC Cancer 2012; 12: 184-203.
  • 3. MacManus MP, Hicks RJ, Ball DL, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with non-small cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 2001; 92: 886-895.
  • 4. Steinfort DP, Hew MJ, Irving LB. Bronchoscopic evaluation of the mediastinum using endobronchial ultrasound: a description of the first 216 cases carried out at an Australian tertiary hospital. Intern Med J 2011; 41: 815-824.
  • 5. Lee CK, Brown C, Gralla RJ, et al. Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis. J Natl Cancer Inst 2013; 105: 595-605.
  • 6. Thomas RK, Greulich H, Yuza Y, et al. Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors. Cold Spring Harb Symp Quant Biol 2005; 70: 73-81.
  • 7. Conron M, Phuah S, Steinfort D, et al. Analysis of multidisciplinary lung cancer practice. Intern Med J 2007; 37: 18-25.
  • 8. Jong KE, Smith DP, Yu XQ, et al. Remoteness of residence and survival from cancer in New South Wales. Med J Aust 180: 618-622. <MJA full text>
  • 9. Cancer Council Australia. Clinical guidelines for the prevention, diagnosis and management of lung cancer. http://wiki.cancer.org.au/australia/Guidelines:Lung_cancer (accessed Oct 2013).
  • 10. Adair T, Hoy D, Detrick Z, Lopez D. Reconstruction of long-term tobacco trends in Australia and their relationship to lung cancer mortality. Cancer Causes Control 2011; 22: 1047-1053.
  • 11. Humphrey L, Deffebach M, Pappas M, et al. Screening for lung cancer: systematic review to update the US Preventive Services Task Force Recommendation [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US), 2013.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.